pmid,title,journal,year,drug,disease
31643292,Imatinib.,,2012,Imatinib,Hepatitis B
38045662,Prevalence and Associated Factors for Thyroid Dysfunction Among Patients On Targeted Therapy for Cancers: A Single-Center Study from Thailand.,Journal of the ASEAN Federation of Endocrine Societies,2023,Imatinib,Hepatitis B
37848004,Viral Infections and Incidence of Reactivations in Chronic Myeloid Leukemia Patients.,Oncology,2024,Imatinib,Hepatitis B
37601670,Management of chronic myelogenous leukemia with COVID-19 and hepatitis B.,Frontiers in oncology,2023,Imatinib,Hepatitis B
37031398,"Kinetic of liver enzymes and serum electrolytes in HCV, HBV, and HIV negative chronic phase chronic myeloid leukemia patients treated with imatinib or nilotinib.",The Egyptian journal of immunology,2023,Imatinib,Hepatitis B
36789996,Imatinib-induced lichen planus and lichenoid drug eruption: A report of three cases.,Journal of cutaneous pathology,2023,Imatinib,Hepatitis B
34575167,Chronic Myeloid Leukemia in Children: Immune Function and Vaccinations.,Journal of clinical medicine,2021,Imatinib,Hepatitis B
34326735,Chronic Myeloid Leukemia in a Patient with Hepatitis B Virus Infection: A Case Report.,Case reports in oncology,2021,Imatinib,Hepatitis B
33680453,Risk of infection associated with targeted therapies for solid organ and hematological malignancies.,Therapeutic advances in infectious disease,2021,Imatinib,Hepatitis B
33552970,Hepatitis B Virus Reactivation in Gastrointestinal Stromal Tumor Patients Treated With Imatinib.,Frontiers in oncology,2020,Imatinib,Hepatitis B
33050924,Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).,Trials,2020,Imatinib,Hepatitis B
33332067,,,2020,Imatinib,Hepatitis B
31291714,Factors Influencing Imatinib-Induced Hepatotoxicity.,Cancer research and treatment,2020,Imatinib,Hepatitis B
30775435,Restriction of hepatitis B virus replication by c-Abl-induced proteasomal degradation of the viral polymerase.,Science advances,2019,Imatinib,Hepatitis B
30732216,Long-term adjuvant imatinib treatment for a patient who underwent complete resection of a localized recurrent gastrointestinal stromal tumor after preoperative imatinib treatment: A case report.,Medicine,2019,Imatinib,Hepatitis B
30687740,Recent Advances in HBV Reactivation Research.,BioMed research international,2018,Imatinib,Hepatitis B
30567202,Imatinib and liver toxicity.,BMJ case reports,2018,Imatinib,Hepatitis B
30079802,Hepatitis B virus reactivation following imatinib therapy: A comparative review of 9 cases.,Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners,2019,Imatinib,Hepatitis B
29663729,Hepatitis B infection reported with cancer chemotherapy: analyzing the US FDA Adverse Event Reporting System.,Cancer medicine,2018,Imatinib,Hepatitis B
29524963,Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature.,Journal of medical case reports,2018,Imatinib,Hepatitis B
30695330,[Molecular Targeted Therapy and Laboratory Tests].,Rinsho byori. The Japanese journal of clinical pathology,2016,Imatinib,Hepatitis B
29201705,Hepatitis B Virus Reactivation under Treatment with Nilotinib.,Euroasian journal of hepato-gastroenterology,2015,Imatinib,Hepatitis B
24982379,Hepatitis B viral reactivation secondary to imatinib treatment in a patient with gastrointestinal stromal tumor.,Anticancer research,2014,Imatinib,Hepatitis B
24944464,Hepatitis C virus reactivation in cancer patients in the era of targeted therapies.,World journal of gastroenterology,2014,Imatinib,Hepatitis B
23483799,Hepatitis B reactivation in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor.,World journal of gastroenterology,2013,Imatinib,Hepatitis B
23336229,[Reactivation of chronic hepatitis B infection related to imatinib mesylate therapy in patients with chronic myeloid leukemia: two cases report and literatures review].,Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,2012,Imatinib,Hepatitis B
22882953,Hepatitis B virus reactivation in a chronic myeloid leukemia patient treated with imatinib mesylate.,Chinese medical journal,2012,Imatinib,Hepatitis B
21225019,Gateways to clinical trials.,Methods and findings in experimental and clinical pharmacology,2010,Imatinib,Hepatitis B
20430187,Living donor liver transplantation for acute hepatic failure caused by reactivation of hepatitis B virus infection after chemotherapy for hematologic malignancy: case reports.,Transplantation proceedings,2010,Imatinib,Hepatitis B
19669326,Reactivation of chronic hepatitis B infection related to imatinib mesylate therapy.,Hepatology international,2008,Imatinib,Hepatitis B
19641858,Chronic myeloid leukemia patient manifesting fatal hepatitis B virus reactivation during treatment with imatinib rescued by liver transplantation: case report and literature review.,International journal of hematology,2009,Imatinib,Hepatitis B
19251803,Tuberculosis complicating imatinib treatment for chronic myeloid leukaemia.,The European respiratory journal,2009,Imatinib,Hepatitis B
18602920,C-kit inhibition by imatinib mesylate attenuates progenitor cell expansion and inhibits liver tumor formation in mice.,Gastroenterology,2008,Imatinib,Hepatitis B
18376233,Phase II study of imatinib in unresectable hepatocellular carcinoma.,American journal of clinical oncology,2008,Imatinib,Hepatitis B
18362995,Imatinib mesylate-related fatal acute hepatic failure in a patient with chronic myeloid leukaemia and chronic hepatitis B infection.,Singapore medical journal,2008,Imatinib,Hepatitis B
16321842,Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment.,Leukemia & lymphoma,2006,Imatinib,Hepatitis B
15017638,GI clinical research 2002-2003: the year in review.,Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,2003,Imatinib,Hepatitis B
12745646,Imatinib Mesylate (Gleevec) is a useful agent in the salvage treatment of adults with relapsed/refractory Philadelphia positive acute leukemias.,"Hematology (Amsterdam, Netherlands)",2003,Imatinib,Hepatitis B
